Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Marco Ruella
Immunotherapy for T-cell lymphoma
Daisuke Nakada
preleukemia, leukemia
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Jenny Wang
AML
Amit Verma
AML/MDS
Jianhua Yu
myeloma immunotherapy
Peter Croucher
Multiple Myeloma
Sham Mailankody
Myeloma immunotherapy clinical trials
Joachim Yahalom
Lymphoma
Jaehyuk Choi
T-cell lymphoma
Anushree Vichare
Equity in Access
Margaret Shipp
lymphoma biology
Kathleen Sakamoto
pediatric AML
Michael Wang
Mantle Cell Lymphoma
Coleman Lindsley
AML/MDS
Courtney Jones
AML metabolism
Affimed
immunotherapy, HL, PTCL
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Anouchka Laurent
T-cell lymphoma
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Nicolas Nassar
pediatric leukemia
Yiman Liu
Epigenetics and leukemia
Venkata Lokesh Battula
immunotherapy and AML
Jeremy Baeten
AML
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Peter Klein
MDS
John Crispino
myelofibrosis, pediatric leukemia and Downs
Michael Savona
MDS and leukemia
Christopher Flowers
clinical trial access
Armin Rashidi
gut bacteria and transplant success
Jonathan Licht
DNA biology, myeloma
Paul Beavis
immunotherapy in myeloma
Auron Therapeutics
degrader, AML, MDS
Simona Colla
Myeloma biology
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Jeffrey Magee
pediatric AML
Jonathon Cohen
lymphoma clinical trial access in Georgia
Tycel Phillips
Mantle Cell Lymphoma
Gianpietro Dotti
CAR T and AML
Jennifer Amengual
lymphomas after transplant
Daniel Lucas
bone marrow and leukemia biology
Rajni Kumari
AML
Britta Will
Leukemia and pre-leukemia
Jing Yang
Myeloma
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Suzanne Lentzsch
Myeloma
Dimericon Therapeutics
dimericons, blood cancer
Michael Keller
COVID-19, immunotherapy
Brian Dalton
DNA mutations and myeloid cancers
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Dan Landau
cancer evolution biology
Lori Muffly
Equity in Access
Sahand Hormoz
MPN
Wendy Béguelin
follicular lymphoma
Jing Fu
myeloma
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Enterome
vaccine, FL, MZL
Roland Walter
Antibody-based AML therapies
Jennifer Woyach
CLL trials
Riccardo Dalla-Favera
lymphoma (DLBCL)
Richard Lock
T-ALL
Yibin Yang
Lymphoma
H. Irene Su
Equity in Access
Steven Treon
Lymphomas and Waldenstrom's
Nataly Cruz-Rodriguez
T-ALL and metabolism
Mendel Goldfinger
MDS/AML trials for the elderly
Justine Kahn
pediatric leukemia and lymphoma
Philippe Armand
follicular lymphoma
Alfred Garfall
myeloma immunotherapy
Suman Paul
T cell cancers and immunotherapy
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM
Catherine Diefenbach
DLBCL immunology
Solu Therapeutics
immunotherapy, CMML
Alex Kentsis
pediatric leukemias
Eugenio Morelli
Myeloma
Christian Marinaccio
MLL leukemias
Carl June
CAR T immunotherapy
Elliot Stieglitz
CMML
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Huda Salman
CMML
Takeshi Sugio
T-cell lymphoma
Matteo Bellone
Smoldering multiple myeloma
Liling Wan
AML
Dane Vassiliadis
blood cancer biology
Meng Li
Equity in Access
Qing Yi
Novel CAR-T
Thomas LeBlanc
palliative care
Jeetayu Biswas
splicing in myeloid diseases
Thomas Kipps
Hairy Cell Leukemia
Daphne Friedman
Equity in Access
Rachel Mersfelder
AMKL
BioInvent International
immunotherapy, indolent NHL, CTCL
F. Lennie Wong
Equity in Access
Pooja Khandelwal
bone marrow transplantation
Cailin Collins
Leukemia and pre-leukemia
Timothy Graubert
AML and MDS biology
Piers Patten
COVID-19
Mala Shanmugam
myeloma
Constellation Pharmaceuticals
myeloproliferative neoplasms
Anthony Letai
improving CAR-T
Brian Walker
smoldering myeloma, MGUS
Helen Parsons
Equity in Access
Bingyi Chen
AML immunotherapy
Eirini Papapetrou
blood cancer stem cells
Shannon Maude
Immunotherapy for ALL
Michaela Reagan
Multiple Myeloma
Craig Jordan
AML
Yoke Seng Lee
AML
Madhav Dhodapkar
multiple myeloma immunotherapy
George Daley
"off-the-shelf" CAR-T and CAR-NK
Kimberly Stegmaier
childhood blood cancers
Christine Zhang
AML
Daniel Thomas
Myelofibrosis
Yan Liu
MDS
Nicola Vannini
Aging and CAR-T success
Tanya Siddiqi
clinical trial access
Caner Saygin
T-ALL
Nizar Bahlis
Myeloma immunotherapy
Sergei Doulatov
Leukemias
Stacie Dusetzina
Equity in Access
Carma Bylund
Equity in Access
Ravi Bhatia
transplantation
Fahmin Basher
transplant and GvHD
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
William Matsui
Myeloma
Robert Soiffer
transplantation
Lawrence Boise
CART and myeloma
Carl Allen
pediatric blood cancers
Rgenta Therapeutics
RNA-targeting, blood cancer
Maximilian Stahl
AML immunotherapy
Tomasz Skorski
myeloproliferative neoplasms, AML
Steven Horwitz
T-cell lymphomas
Roberta Zappasodi
lymphoma, immunotherapy
Catherine Smith
leukemia
Jayna Mistry
aging and leukemias
Matthew Frank
Lymphoma CART therapy
Sigurður Kristinsson
Smoldering myeloma
Hao Jiang
DNA biology and leukemia
Keisuke Ito
blood cancer stem cells and MDS metabolism
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Nitin Jain
CLL
ImCheck Therapeutics
immunotherapy, AML
Wendy Stock
T-cell ALL
Caroline Arber
myeloma CAR-T
Rong Lu
preleukemia, leukemia
Jennifer Trowbridge
aging and leukemia
Daniel Pollyea
AML
Jalpa Doshi
Equity in Access
Jianguo Tao
Mantle Cell Lymphoma
Fenghuang Zhan
Myeloma and bone disease
Teresa Palomero
Peripheral T-cell Lymphoma
Robert Orlowski
(Smoldering) Multiple Myeloma
Marc Seifert
Hairy cell leukemia
Mark Hamilton
DLBCL and CAR-T
Paolo Strati
Non-Hodgkin Lymphoma
Qingyu Luo
BPDCN
Noemí Puig Morón
Myeloma
Adi Nagler
Bronchiolitis obliterans after transplant
Michael Kharas
leukemia
Ravindra Majeti
preleukemia, AML
Siddhartha Jaiswal
preleukemia
Alieen Rowan
Adult T cell leukemia/lymphoma
Sheng Li
Aging and AML
Julia Maxson
AML
Urvi Shah
Diet and myeloma
Hong Wen
AML
Enrico Tiacci
Hairy cell leukemia
Nicoletta Cieri
AML and transplantation
Steven Park
follicular lymphoma
Marina Konopleva
MDS/AML metabolism
Yubin Zhou
peripheral T cell lymphoma
Shazia Nakhoda
Equity in Access
Christopher Porter
Leukemia, lymphoma
Paolo Caimi
CAR-T clinical trial for CLL
Kerry Rogers
CLL
Markus Muschen
leukemia and lymphoma biology
Manyi Wei
acute megakaryoblastic leukemia
Reina Takeda
AML
Eric Pietras
AML
Sriram Sundaravel
AML stem cells
Liran Shlush
pre-leukemia
Bing Carter
p53 mutant AML
Adam de Smith
pediatric ALL and Down Syndrome
Jonas Jutzi
myeloproliferative neoplasms
Stephen Nimer
myeloid cancer biology
Rizwan Romee
Immunotherapy
Gaurav Goyal
Erdheim-Chester Disease
Andrew Lane
BPDCN
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Bruno Paiva
smoldering myeloma
Catherine Bollard
pediatric blood cancers and immunotherapy
Ricky Johnstone
lymphoma and myeloma
Bailee Kain
AML and African ancestry
Eric Padron
CMML
Nirav Shah
CAR-T for lymphoma
Tak Mak
Immunotherapy
Kasey Leger
pediatric blood cancers
Stephen Gottschalk
pediatric leukemia and CAR-T
Taishi Yonezawa
AML
Leandro Cerchietti
DLBCL
Faron Pharmaceuticals
immunotherapy, MDS
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Ruben Carrasco
Myeloma
Michael Green
lymphoma biology
Siegfried Janz
Myeloma immunotherapy
Raymond Mailhot
Equity in Access
Jun Qi
Myeloma
Megan McNerney
AML/MDS
James Rubenstein
Lymphoma of the Central Nervous System
Ronald Levy
immunotherapies, COVID-19
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Sarah Tasian
pediatric leukemias
Lev Kats
myeloma and epigenetics
Neha Mehta-Shah
T-cell lymphoma
Julia Paczkowska
immunobiology of Hodgkin's disease
Koichi Takahashi
AML/MDS
Jake Shortt
precision therapy for aggressive lymphomas
Grzegorz Nowakowski
Clinical trial access
Kura Oncology
MLL leukemia, AML
Daniel Herranz
T-ALL
John DiPersio
trispecific antibody for AML and MDS
Courtney DiNardo
clinical trials, AML
Luca Busino
DLBCL
Oreofe Odejide
Equity in Access
Xu Ji
Equity in Access
Lindsey Montefiori
pediatric leukemia
Lucy Godley
preleukemia
Alexey Danilov
lymphoma
Christian Steidl
B-cell lymphomas
Mark Dawson
B-ALL and CAR-T resistance
Saar Gill
AML immunotherapy
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Trent Hall
MDS
Mark Murakami
follicular lymphoma
Frederick Locke
lymphoma and immunotherapy
John Leonard
lymphoma research
Randall Davis
CLL
Thomas Koehnke
leukemia
Ari Melnick
epigenetics and lymphoma
Soheil Meshinchi
pediatric AML
Caron Jacobson
lymphoma and immunotherapy
Ana Vujovic
AML
Jean Koff
Disparities in DLBCL
Catriona Jamieson
cancer stem cell biology
Logan Spector
childhood leukemia epidimiology
Adam Olszewski
Follicular and marginal zone lymphoma
Pietro Genovese
transplant and AML
Grant Challen
preleukemia, leukemia
George Vassiliou
Leukemia Prevention
Srividya Swaminathan
pediatric, immunotherapy
Ann-Kathrin Eisfeld
Racial diversity in AML
Jessica Stewart
Epstein-barr virus and lymphomas
Omar Abdel-Wahab
Hairy cell leukemia
Sam Butterworth
CMML
Inhye Ahn
CLL
Tyler Parsons
MPN and AML
Andrew Hantel
Equity in Access
Jolanta Grembecka
leukemia therapeutics
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Christopher Booth
BPDCN
Martin Dreyling
Mantle Cell Lymphoma
Kirk Schultz
pediatric transplantation